|
|
A Message from Paul V. Campanelli
President, Par Pharmaceutical
|
For more than three decades, Par Pharmaceutical has been driven by one principle – Quality. Uncompromised quality for patients and our customers.
Our team has made quality the cornerstone of what we are as an organization and who we are as individuals. We deliver on this commitment each day by providing high-quality, affordable drugs to our customers, and industry-leading customer-service levels to generate superior, long-term returns to our customers, partners and shareholders.
As a partner of choice for both product development programs and Authorized Generics, we take immense pride in our entrepreneurial business-development strategy. We have built this strategy on intelligent product selection, commercialization excellence and operational effectiveness.
Our strategy has played a crucial role in building our record of not only being the first to anticipate customer needs but also quickly and cost effectively meeting those needs. Its distinguishing features include a sharp focus on niche, high-barrier-to-entry products that have limited competition and long life cycles; expertise in product patents, modified release technology and delivery systems; and first-to-market generic drug successes.
As the pharmaceutical industry continues to undergo tremendous change, there are two facts of which we are certain: we will continue to fulfill our commitment to provide high-quality generic pharmaceuticals, and quality will always come first.
|
Paul V. Campanelli
President
Par Pharmaceutical
|
|
|
|
